Biblio

Export 1352 results:
Author Title [ Type(Asc)] Year
Filters: First Letter Of Last Name is P  [Clear All Filters]
Journal Article
M. Brendel, Sauerbeck, J., Greven, S., Kotz, S., Scheiwein, F., Blautzik, J., Delker, A., Pogarell, O., Ishii, K., Bartenstein, P., and Rominger, A., “Serotonin Selective Reuptake Inhibitor Treatment Improves Cognition and Grey Matter Atrophy but not Amyloid Burden During Two-Year Follow-Up in Mild Cognitive Impairment and Alzheimer's Disease Patients with Depressive Symptoms.”, J Alzheimers Dis, vol. 65, no. 3, pp. 793-806, 2018.
G. S. Smith, Kuwabara, H., Yan, H., Nassery, N., Yoon, M., Kamath, V., Kraut, M., Gould, N. F., Savonenko, A., Coughlin, J. M., Lodge, M., Pomper, M. G., Nandi, A., Holt, D., Dannals, R. F., and Leoutsakos, J. M., “Serotonin Degeneration and Amyloid-β Deposition in Mild Cognitive Impairment: Relationship to Cognitive Deficits.”, J Alzheimers Dis, vol. 96, no. 1, pp. 215-227, 2023.
S. Klöppel, Kotschi, M., Peter, J., Egger, K., Hausner, L., Frölich, L., Förster, A., Heimbach, B., Normann, C., Vach, W., Urbach, H., and Abdulkadir, A., “Separating Symptomatic Alzheimer's Disease from Depression based on Structural MRI.”, J Alzheimers Dis, vol. 63, no. 1, pp. 353-363, 2018.
S. Nave, Doody, R. S., Boada, M., Grimmer, T., Savola, J. - M., Delmar, P., Pauly-Evers, M., Nikolcheva, T., Czech, C., Borroni, E., Ricci, B., Dukart, J., Mannino, M., Carey, T., Moran, E., Gilaberte, I., Muelhardt, N. Milani, Gerlach, I., Santarelli, L., Ostrowitzki, S., and Fontoura, P., “Sembragiline in Moderate Alzheimer's Disease: Results of a Randomized, Double-Blind, Placebo-Controlled Phase II Trial (MAyflOwer RoAD).”, J Alzheimers Dis, vol. 58, no. 4, pp. 1217-1228, 2017.
B. M. Brown, Rainey-Smith, S. R., Doré, V., Peiffer, J. J., Burnham, S. C., Laws, S. M., Taddei, K., Ames, D., Masters, C. L., Rowe, C. C., Martins, R. N., and Villemagne, V. L., “Self-Reported Physical Activity is Associated with Tau Burden Measured by Positron Emission Tomography.”, J Alzheimers Dis, vol. 63, no. 4, pp. 1299-1305, 2018.
J. L. Conde-Sala, Turró-Garriga, O., Portellano-Ortiz, C., Viñas-Diez, V., Gascón-Bayarri, J., and Reñé-Ramírez, R., “Self-Perceived Quality of Life Among Patients with Alzheimer's Disease: Two Longitudinal Models of Analysis.”, J Alzheimers Dis, vol. 52, no. 3, pp. 999-1012, 2016.
L. Vaskivuo, Hokkanen, L., Hänninen, T., Antikainen, R., Bäckman, L., Laatikainen, T., Paajanen, T., Stigsdotter-Neely, A., Strandberg, T., Tuomilehto, J., Soininen, H., Kivipelto, M., and Ngandu, T., “Self and Informant Memory Reports in FINGER: Associations with Two-Year Cognitive Change.”, J Alzheimers Dis, vol. 71, no. 3, pp. 785-795, 2019.
R. H. L. H. Rueli, Torres, D. J., Dewing, A. S. T., Kiyohara, A. C., Barayuga, S. M., Bellinger, M. T., Uyehara-Lock, J. H., White, L. R., Moreira, P. I., Berry, M. J., Perry, G., and Bellinger, F. P., “Selenoprotein S Reduces Endoplasmic Reticulum Stress-Induced Phosphorylation of Tau: Potential Role in Selenate Mitigation of Tau Pathology.”, J Alzheimers Dis, vol. 55, no. 2, pp. 749-762, 2017.
N. D. DiProspero, Keator, D. B., Phelan, M., van Erp, T. G. M., Doran, E., Powell, D. K., Van Pelt, K. L., Schmitt, F. A., Head, E., Lott, I. T., and Yassa, M. A., “Selective Impairment of Long-Range Default Mode Network Functional Connectivity as a Biomarker for Preclinical Alzheimer's Disease in People with Down Syndrome.”, J Alzheimers Dis, vol. 85, no. 1, pp. 153-165, 2021.
N. D. DiProspero, Keator, D. B., Phelan, M., van Erp, T. G. M., Doran, E., Powell, D. K., Van Pelt, K. L., Schmitt, F. A., Head, E., Lott, I. T., and Yassa, M. A., “Selective Impairment of Long-Range Default Mode Network Functional Connectivity as a Biomarker for Preclinical Alzheimer's Disease in People with Down Syndrome.”, J Alzheimers Dis, vol. 85, no. 1, pp. 153-165, 2021.
Y. E. Cruz-Rivera, Perez-Morales, J., Santiago, Y. M., Gonzalez, V. M., Morales, L., Cabrera-Rios, M., and Isaza, C. E., “A Selection of Important Genes and Their Correlated Behavior in Alzheimer's Disease.”, J Alzheimers Dis, vol. 65, no. 1, pp. 193-205, 2018.
L. D. Van Mierlo, Wouters, H., Sikkes, S. A. M., van der Flier, W. M., Prins, N. D., Bremer, J. A. E., Koene, T., and Van Hout, H. P. J., “Screening for Mild Cognitive Impairment and Dementia with Automated, Anonymous Online and Telephone Cognitive Self-Tests.”, J Alzheimers Dis, vol. 56, no. 1, pp. 249-259, 2017.
Y. Peng, Zhang, L., Zhou, F., Wang, Y., Zhang, X., Fan, J., Li, S., Li, X., and Li, Y., “Scavenging Reactive Oxygen Species Decreases Amyloid-β Levels via Activation of PI3K/Akt/GLUT1 Pathway in N2a/APP695swe Cells.”, J Alzheimers Dis, vol. 90, no. 1, pp. 185-198, 2022.
C. Peters-Libeu, Campagna, J., Mitsumori, M., Poksay, K. S., Spilman, P., Sabogal, A., Bredesen, D. E., and John, V., “sAβPPα is a Potent Endogenous Inhibitor of BACE1.”, J Alzheimers Dis, vol. 47, no. 3, pp. 545-55, 2015.
C. Peters-Libeu, Campagna, J., Mitsumori, M., Poksay, K. S., Spilman, P., Sabogal, A., Bredesen, D. E., and John, V., “sAβPPα is a Potent Endogenous Inhibitor of BACE1.”, J Alzheimers Dis, vol. 47, no. 3, pp. 545-55, 2015.
V. Valdiglesias, Maseda, A., Lorenzo-López, L., Pásaro, E., Millán-Calenti, J. C., and Laffon, B., “Is Salivary Chromogranin A a Valid Psychological Stress Biomarker During Sensory Stimulation in People with Advanced Dementia?”, J Alzheimers Dis, vol. 55, no. 4, pp. 1509-1517, 2017.
A. Palmeri, Mammana, L., Tropea, M. Rosaria, Gulisano, W., and Puzzo, D., “Salidroside, a Bioactive Compound of Rhodiola Rosea, Ameliorates Memory and Emotional Behavior in Adult Mice.”, J Alzheimers Dis, vol. 52, no. 1, pp. 65-75, 2016.
A. Palmeri, Mammana, L., Tropea, M. Rosaria, Gulisano, W., and Puzzo, D., “Salidroside, a Bioactive Compound of Rhodiola Rosea, Ameliorates Memory and Emotional Behavior in Adult Mice.”, J Alzheimers Dis, vol. 52, no. 1, pp. 65-75, 2016.
M. Pejstrup Agger, Danielsen, E. Rubæk, Carstensen, M. Schultz, N Nguyen, M., Horning, M., Henney, M. Alexander, Jensen, C. Boe Ravn, Baandrup, A. Ohlhues, Kjær, T. Wesenberg, Madsen, K. Hougaard, Miskowiak, K., Petersen, P. Michael, and Høgh, P., “Safety, Feasibility, and Potential Clinical Efficacy of 40 Hz Invisible Spectral Flicker versus Placebo in Patients with Mild-to-Moderate Alzheimer's Disease: A Randomized, Placebo-Controlled, Double-Blinded, Pilot Study.”, J Alzheimers Dis, vol. 92, no. 2, pp. 653-665, 2023.
E. Lacorte, Ancidoni, A., Zaccaria, V., Remoli, G., Tariciotti, L., Bellomo, G., Sciancalepore, F., Corbo, M., Lombardo, F. L., Bacigalupo, I., Canevelli, M., Piscopo, P., and Vanacore, N., “Safety and Efficacy of Monoclonal Antibodies for Alzheimer's Disease: A Systematic Review and Meta-Analysis of Published and Unpublished Clinical Trials.”, J Alzheimers Dis, vol. 87, no. 1, pp. 101-129, 2022.
A. Shelef, Barak, Y., Berger, U., Paleacu, D., Tadger, S., Plopsky, I., and Baruch, Y., “Safety and Efficacy of Medical Cannabis Oil for Behavioral and Psychological Symptoms of Dementia: An-Open Label, Add-On, Pilot Study.”, J Alzheimers Dis, vol. 51, no. 1, pp. 15-9, 2016.
A. Shelef, Barak, Y., Berger, U., Paleacu, D., Tadger, S., Plopsky, I., and Baruch, Y., “Safety and Efficacy of Medical Cannabis Oil for Behavioral and Psychological Symptoms of Dementia: An-Open Label, Add-On, Pilot Study.”, J Alzheimers Dis, vol. 51, no. 1, pp. 15-9, 2016.
V. Leinonen, Rauramaa, T., Johansson, J., Bottelbergs, A., Tesseur, I., van der Ark, P., Pemberton, D., Koivisto, A. M., Jääskeläinen, J. E., Hiltunen, M., Herukka, S. - K., Blennow, K., Zetterberg, H., Jokinen, P., Rokka, J., Helin, S., Haaparanta-Solin, M., Solin, O., Okamura, N., Kolb, H. C., and Rinne, J. O., “S-[18F]THK-5117-PET and [11C]PIB-PET Imaging in Idiopathic Normal Pressure Hydrocephalus in Relation to Confirmed Amyloid-β Plaques and Tau in Brain Biopsies.”, J Alzheimers Dis, vol. 64, no. 1, pp. 171-179, 2018.
M. Alegret, Peretó, M., Pérez, A., Valero, S., Espinosa, A., Ortega, G., Hernandez, I., Mauleón, A., Rosende-Roca, M., Vargas, L., Rodríguez-Gómez, O., Abdelnour, C., Berthier, M. L., Bak, T. H., Ruiz, A., Tárraga, L., and Boada, M., “The Role of Verb Fluency in the Detection of Early Cognitive Impairment in Alzheimer's Disease.”, J Alzheimers Dis, vol. 62, no. 2, pp. 611-619, 2018.
M. Alegret, Peretó, M., Pérez, A., Valero, S., Espinosa, A., Ortega, G., Hernandez, I., Mauleón, A., Rosende-Roca, M., Vargas, L., Rodríguez-Gómez, O., Abdelnour, C., Berthier, M. L., Bak, T. H., Ruiz, A., Tárraga, L., and Boada, M., “The Role of Verb Fluency in the Detection of Early Cognitive Impairment in Alzheimer's Disease.”, J Alzheimers Dis, vol. 62, no. 2, pp. 611-619, 2018.

Pages